Brokerages expect diagnostic majors to sustain volume growth through FY27, aided by robust demand and stable pricing, though the recent stock rally may cap upside
Growth triggers, new brand partnerships and regulatory tailwinds offer support, but a rerating hinges on stronger volumes and growth rates as valuations remain elevated
Rising competition in wires and cables, higher copper and aluminium prices and elevated advertising spending are expected to weigh on Havells India's margins
Strong domestic growth, a chronic-heavy portfolio, JB Pharma integration benefits and gains in semaglutide are expected to support Torrent Pharma's near-term performance
Stabilising PVC prices, channel restocking and demand recovery are expected to support Q2FY27 performance, while the company retains its FY27 volume and margin guidance
HUL is betting on premiumisation, consumption and new categories to drive volume-led growth, but analysts await clarity on the pace and timeline of recovery
Strong launch pipeline, improving balance sheet and potential gains from higher land prices at Palava underpin brokerages' positive outlook on Lodha Developers
Focus on core categories, innovation and new businesses offers growth potential, but analysts say consistent delivery under the new leadership will be critical
Broad-based category growth, premiumisation and localisation support LG Electronics India's outlook, though the recent stock rally has raised valuation concerns
Brokerages have raised Bosch's FY27 earnings estimates by 3-11 per cent after a strong June quarter, while the stock has rallied 17.7 per cent over the past month
Strong volume growth in Europe and India is expected to support Balkrishna Industries, while calibrated price increases could help margins recover gradually
The move opens a larger addressable market but analysts see state-level regulatory complexity, limited distribution synergies and weak near-term earnings contribution